011312 NIACINAMIDE 4% / TAZAROTENE 0.05%
011312 NIACINAMIDE 4% / TAZAROTENE 0.05%
Approved
Approval ID
a97a190f-1f98-1fb0-e053-2a95a90a6850
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 2, 2020
Manufacturers
FDA
Sincerus Florida, LLC
DUNS: 080105003
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
011312 NIACINAMIDE 4% / TAZAROTENE 0.05%
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72934-2208
Product Classification
G
Generic Name
011312 NIACINAMIDE 4% / TAZAROTENE 0.05%
Product Specifications
Route of AdministrationTOPICAL
Effective DateJuly 2, 2020
FDA Product Classification
INGREDIENTS (2)
TAZAROTENEActive
Quantity: 0.05 g in 100 g
Code: 81BDR9Y8PS
Classification: ACTIB
NIACINAMIDEActive
Quantity: 4 g in 100 g
Code: 25X51I8RD4
Classification: ACTIB